Patent: 10,279,048
Summary for Patent: 10,279,048
| Title: | Stabilizing excipients for therapeutic protein formulations |
| Abstract: | The invention encompasses therapeutic formulations comprising a protein active ingredient and a stabilizing excipient, methods of improving stability in a therapeutic formulation comprising a protein active ingredient by adding a stability-improving amount of a stabilizing excipient to the therapeutic formulation, and methods of reducing adverse infusion-related effects in a patient, comprising administering to a patient in need thereof a therapeutic formulation comprising a protein active ingredient and a stabilizing excipient. |
| Inventor(s): | Soane; David S. (Palm Beach, FL), Mahoney; Robert P. (Newbury, MA), Wuthrich; Philip (Belmont, MA), Greene; Daniel G. (Belmont, MA) |
| Assignee: | REFORM BIOLOGICS, LLC (Woborn, MA) |
| Application Number: | 15/647,669 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,279,048
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | May 5, 2004 | 10,279,048 | 2037-07-12 |
| Bausch & Lomb Incorporated | VITRASE | hyaluronidase | Injection | 021640 | December 2, 2004 | 10,279,048 | 2037-07-12 |
| Amphastar Pharmaceuticals, Inc. | AMPHADASE | hyaluronidase | Injection | 021665 | October 26, 2004 | 10,279,048 | 2037-07-12 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
